- Dr. Judy Garber comments on a U.S. Preventive Services Task Force recommendation that women at high risk for breast cancer consider taking drugs to prevent the disease.
Tags: BreastCancer, Prevention
- Dr. Beth Overmoyer said women with Inflammatory Breast Cancer are often initially misdiagnosed because most doctors are not familiar with the disease.
- Dana-Farber is seeking alternative sources for research funding amid a downward trend in the money received from the federal government.
- Dr. Nikhil Wagle led a study that found a patient with advanced bladder cancer experienced a complete response for 14 months to the drug combination Everolimus and Pazopanib.
- A study in the journal Cancer suggests that breast cancer patients who opt for lumpectomies with radiation might have a small survival advantage compared with those who have mastectomies. Dr. Mehra Golshan says it is hard to imagine that less surgery with radiation gives a better outcome.
Tags: BreastCancer, Radiation
- Lung cancer among younger, healthier, and non-smoking individuals "seems to be emerging as its own subtype of lung cancer — one for which new, powerful treatments are needed to make it a livable disease" said Dr. Geoffrey Oxnard, a lung cancer specialist at Dana-Farber Cancer Institute.
Tags: LungCancer, Genetics
- The Savage family moved to Boston from Ireland so that their daughter could be treated by Dana-Farber specialists for a rare form of brain cancer.
Tags: ChildhoodCancer, BrainTumors
- A study by Dr. Susan Dale Block found that the less money spent on medical care at the end of a person’s life resulted in a better death experience.
Showing 1-10 of 425 items